Ticker Details
Apogee Therapeutics, Inc.
IPO Date:	July 14, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.67B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.14 | 2.73%
Avg Daily Range (30 D):	$1.87 | 2.65%
Avg Daily Range (90 D):	$1.45 | 2.18%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.83M
Avg Daily Volume (90 D):	.72M

Trade Size
Avg Trade Size (Sh.):	55
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	1,501
Avg Institutional Trade:	$2.96M
Avg Institutional Trade (30 D):	$3.43M
Avg Institutional Trade (90 D):	$3.81M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.58M
Avg Closing Trade (30 D):	$6.7M
Avg Closing Trade (90 D):	$8.09M
Avg Closing Volume:	95.56K

News

Jan 6, 2026 @ 11:00 AM Apogee Therapeutics Announces Positive Interim Res... Source: Na

Nov 10, 2025 @ 12:00 PM Apogee Therapeutics Announces Positive Interim Pha... Source: Apogee Therapeutics

Oct 10, 2025 @ 8:01 PM Apogee Therapeutics, Inc. Announces Closing of Pub... Source: Apogee Therapeutics, Inc.

Oct 9, 2025 @ 9:26 PM Why Apogee Therapeutics Stock Triumphed on Thursda... Source: Eric Volkman

Oct 9, 2025 @ 1:52 AM Apogee Therapeutics, Inc. Announces Pricing of $30... Source: Apogee Therapeutics, Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-1.11	$-1.13
Diluted EPS		$-1.11	$-1.13
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-65.02M	$-66.1M
Operating Income / Loss		$-71.28M	$-73.17M
Cost of Revenue
Net Cash Flow		$-16.57M	$17.28M
PE Ratio

Splits
Jan 08, 2008	1:50